Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.47 |
| ▸ | RAB9A | P51151 | 5/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.47 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.47 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.46 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.46 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.44 |
| ▸ | ACLY | P53396 | 2/20 | 0.43 |
| ▸ | ABL1 | P00519 | 4/20 | 0.43 |
| ▸ | SRC | P12931 | 4/20 | 0.43 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6445872 | 0.89 | NPC1 (0.53) | NPC1RAB9ASMN1; SMN2KDM4ECSNK2A2 | |
| SCHEMBL6446020 | 0.86 | KMT2A (0.48) | NPC1RAB9ASMN1; SMN2KDM4ECSNK2A2 | |
| SCHEMBL6444549 | 0.85 | NPC1 (0.46) | NPC1RAB9ASMN1; SMN2KDM4ECSNK2A2 | |
| SCHEMBL6447131 | 0.85 | ABL1 (0.46) | NPC1RAB9ASMN1; SMN2KDM4ECSNK2A2 | |
| SCHEMBL6445844 | 0.85 | ABL1 (0.48) | NPC1RAB9ASMN1; SMN2KDM4ECSNK2A2 | |
| SCHEMBL6447140 | 0.84 | PTGER3 (0.45) | NPC1RAB9ASMN1; SMN2KDM4ECSNK2A2 | |
| SCHEMBL6451555 | 0.84 | CSNK2A2 (0.55) | NPC1RAB9ASMN1; SMN2KDM4ECSNK2A2 | |
| SCHEMBL6445925 | 0.83 | MAPT (0.53) | NPC1RAB9ASMN1; SMN2KDM4ECSNK2A2 | |
| SCHEMBL6447202 | 0.83 | KMT2A (0.46) | NPC1RAB9ASMN1; SMN2KDM4EMEN1 | |
| SCHEMBL6449394 | 0.82 | TAS1R3 (0.49) | NPC1RAB9ASMN1; SMN2KDM4ETAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050143384-A1 | Amide thiadiazole inhibitors of plasminogen activator inhibitor-1 | BRISTOL-MYERS SQUIBB COMPANY | 2005-06-30 | — | — | US | claimed |
| US-20050143384-A1 | Amide thiadiazole inhibitors of plasminogen activator inhibitor-1 | BRISTOL-MYERS SQUIBB COMPANY | 2005-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143384-A1 | Amide thiadiazole inhibitors of plasminogen activator inhibitor-1 | SERPINE1, SERPINC1, SERPINB1 | NPC1 1404/4885RAB9A 1792/4885SMN1; SMN2 2751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.